Timing of blood thinner during heart catheterization
Part of Heart & circulation clinical trials.
This study looks at the best time to give a standard blood thinner (heparin) during a heart procedure called angioplasty, which opens blocked heart arteries through a wrist artery. It may help reduce bleeding or clotting risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are having a heart artery procedure (angioplasty) done through the wrist
- You have not had a serious bleeding episode in the last 6 months
- You are not already taking blood thinners like warfarin, apixaban, or rivaroxaban
- You are not pregnant or breastfeeding
- You can understand the study and give your consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two blood thinners (bivalirudin and heparin) during a procedure to open blocked heart arteries (PCI) in patients with a recent heart attack or unstable angina who also have a high risk of bleeding. The goal is to see which drug works better and is safer for patients like you.
This trial tests whether giving a blood-thinner called heparin to all patients during a procedure through the wrist (radial artery) is better than giving it only when needed. The goal is to see which approach reduces the risk of the artery getting blocked afterward.
This study compares the best way to give blood thinners around certain heart procedures (TEER or left atrial appendage closure). It aims to lower the risk of dangerous clots and bleeding during and after the procedure.
This trial tests whether using a blood thinner in people with new, temporary atrial fibrillation after CABG (heart bypass surgery) can reduce harmful outcomes compared with standard treatment. It may help prevent stroke or other complications if your rhythm problem fits the trial’s timing and risk profile.
This trial tests if a blood thinner called Rivaroxaban can treat a blood clot that forms in the wrist artery after a heart catheterization. If you have this clot, taking Rivaroxaban may help reopen the artery and improve blood flow.
This trial studies which blood-thinning medicine combination is safest and most helpful after coronary bypass surgery combined with a procedure to unblock the artery (endarterectomy). It focuses on preventing dangerous blood clots while also avoiding excess bleeding.
Hear when a new Coronary Angiography trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.